Importance of the Immune Microenvironment in the Spontaneous Regression of Cervical Squamous Intraepithelial Lesions (cSIL) and Implications for Immunotherapy

por Muntinga, Caroline L. P., de Vos van Steenwijk, Peggy J., Bekkers, Ruud L. M., van Esch, Edith M. G.
Publicado 2022

Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis

por Ma, Wenbo, Tummers, Bart, van Esch, Edith M.G., Goedemans, Renske, Melief, Cornelis J.M., Meyers, Craig, Boer, Judith M., van der Burg, Sjoerd H.
Publicado 2016

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation

por Tummers, Bart, Goedemans, Renske, Pelascini, Laetitia P. L., Jordanova, Ekaterina S., van Esch, Edith M. G., Meyers, Craig, Melief, Cornelis J. M., Boer, Judith M., van der Burg, Sjoerd H.
Publicado 2015

Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination

por Abdulrahman, Ziena, de Miranda, Noel, van Esch, Edith M G, de Vos van Steenwijk, Peggy J, Nijman, Hans W, J. P. Welters, Marij, van Poelgeest, Mariette I E, van der Burg, Sjoerd H
Publicado 2020

A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunother...

por Abdulrahman, Ziena, de Miranda, Noel F. C. C., Hellebrekers, Bart W. J., de Vos van Steenwijk, Peggy J., van Esch, Edith M. G., van der Burg, Sjoerd H., van Poelgeest, Mariette I. E.
Publicado 2020

Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions

por Abdulrahman, Ziena, Hendriks, Natasja, J Kruse, Arnold, Somarakis, Antonios, J M van de Sande, Anna, J van Beekhuizen, Heleen, M J Piek, Jurgen, de Miranda, Noel F C C, Kooreman, Loes F S, F M Slangen, Brigitte, van der Burg, Sjoerd H, de Vos van Steenwijk, Peggy J, van Esch, Edith M G
Publicado 2022

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

por van Poelgeest, Mariette I E, Welters, Marij J P, van Esch, Edith M G, Stynenbosch, Linda F M, Kerpershoek, Gijs, van Persijn van Meerten, Els L, van den Hende, Muriel, Löwik, Margriet J G, Berends-van der Meer, Dorien M A, Fathers, Lorraine M, Valentijn, A Rob P M, Oostendorp, Jaap, Fleuren, Gert Jan, Melief, Cornelis J M, Kenter, Gemma G, van der Burg, Sjoerd H
Publicado 2013